Growing community of inventors

Shanghai, China

Weichun Chen

Average Co-Inventor Count = 3.79

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Weichun ChenFeng Ren (2 patents)Weichun ChenXichen Lin (2 patents)Weichun ChenTing Yang (2 patents)Weichun ChenHongfu Lu (2 patents)Weichun ChenZhongmiao Xu (2 patents)Weichun ChenEbere F Igboko (2 patents)Weichun ChenWei Zhang (1 patent)Weichun ChenJunli Chen (1 patent)Weichun ChenXing Liang (5 patents)Weichun ChenGuocai Zhang (1 patent)Weichun ChenHasane Ratni (2 patents)Weichun ChenPaul Bryan Wren (2 patents)Weichun ChenLindong Zhu (1 patent)Weichun ChenLingdong Zhu (1 patent)Weichun ChenChristian Jenny (1 patent)Weichun ChenFugui Zhang (0 patent)Weichun ChenQiwu Zhao (0 patent)Weichun ChenWeichun Chen (4 patents)Feng RenFeng Ren (23 patents)Xichen LinXichen Lin (22 patents)Ting YangTing Yang (8 patents)Hongfu LuHongfu Lu (7 patents)Zhongmiao XuZhongmiao Xu (4 patents)Ebere F IgbokoEbere F Igboko (2 patents)Wei ZhangWei Zhang (29 patents)Junli ChenJunli Chen (7 patents)Xing LiangXing Liang (5 patents)Guocai ZhangGuocai Zhang (3 patents)Hasane RatniHasane Ratni (2 patents)Paul Bryan WrenPaul Bryan Wren (2 patents)Lindong ZhuLindong Zhu (1 patent)Lingdong ZhuLingdong Zhu (1 patent)Christian JennyChristian Jenny (1 patent)Fugui ZhangFugui Zhang (0 patent)Qiwu ZhaoQiwu Zhao (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hoffmann-la Roche Inc. (2 from 4,942 patents)

2. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)

3. F. Hoffmann-la Roche Ag (168 patents)


4 patents:

1. 12319686 - Process for the preparation of tetrahydropyridopyrimidines

2. 12275709 - Process for the preparation of exo-tert-butyl N-(3-azabicyclo[3.2.1]octan-8-yl)carbamate

3. 10336719 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

4. 10106515 - 1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…